Microlearning Topics
Immunology: Introduction
Immunology: Learning Objectives
Immunology: Introduction
Immunology: Introduction
Introduction to Therapeutic Immunology
Therapeutic Immunology: Immunodiagnostics and Immunotherapy
Additional concepts in MS Therapy
Immunologic Concepts
Introduction to Therapeutic Immunology
Traditional Immunosuppressive Agents
Introduction to Therapeutic Immunology
Vaccination Successes
Introduction to Therapeutic Immunology
Immunotherapy
Introduction to Therapeutic Immunology
Biologic Therapies
Introduction to Therapeutic Immunology
Categories of Biologic Therapy
Introduction to Therapeutic Immunology
Edward Jenner: Vaccination
Introduction to Therapeutic Immunology
Limitations of Traditional Immunosuppressive Drugs
Introduction to Therapeutic Immunology
Edward Jenner: Vaccination
Vaccination Successes
Therapeutic Immunology: Immunodiagnostics...
B Cells and Humoral-Mediated Immune Responses
Overview: Immunology
Cytokines
Overview: Cytokines
Traditional Immunosuppressive Therapies
Fungal or Bacterial Derivatives
Traditional Immunosuppressive Therapies
Traditional Immunosuppressive Therapies
Traditional Immunosuppressive Agents
Corticosteroi...
Autoimmune Disease Examples
Autoimmune Diseases
Interactive Exercise: Immunology Terms
Interactivity: Autoimmune Disea...
Cells of the Immune System
The Lymphatic System
Lymphoid Organs
Lymph Node
Lymph Node: T Cell Activation
Ly...
The Inflammatory Response
Inflammation
Inflammation Resolving
Hypersensitivity
Antibody-Mediated Hypersensitivity
T Cells and Cell-Mediated Responses
T Cell Activation
T Cells and Cell-Mediated Immune Responses
T-Cell Activation
Inflammatory Response in Action
Acute Inflammation
Introduction to Monoclonal Antibodies
Antibodies as Therapy
Introduction to Monoclonal Antibodies
The Hybridoma Breakthrough
Introduction to Monoclonal Antibodies
Recombinant mAbs
Cells of the Immune System
Spleen
The Inflammatory Response
The Complement System: Outcomes
The Innate and Adaptive Immune System
The Innate and Adaptive Immune System
Inflammatory Response in Action
Chronic Inflammation
Autoimmune Disease Examples
Autoimmune Diseases
Hypersensitivity
Hypersensitivity Diseases
Hypersensitivity
Types of Hypersensitivity Responses
Traditional Immunosuppressive Therapies
Corticosteroids
Traditional Immunosuppressive Therapies
Cytotoxic Agents
T Cells and Cell-Mediated Immune Responses
T-Cell Activation
The Inflammatory Response
Inflammation Resolving
The Immune Response: Overview
The Immune Response: Overview
The Immune Response
The Skin Barrier
The Innate Immune Response
Inflammatory Gene Transcription
The Immune Response
The Adaptive (or Acquired) Immune Response
Cells of the Immune System
The Lymphatic System
Cells of the Immune System
Lymph Node
Overview: The Inflammatory Response
Overview: The Inflammatory Response
The Inflammatory Response
Leukocyte Migration: Rolling and adhesion
The Inflammatory Response
The Complement System: The Complement
Complement System in Action
The Complement Cascade
Complement System in Action
Activation of Complement
The Inflammatory Response
Phagocytosis
Cytokines
Tumor Necrosis Factor Alpha in Disease
Self vs. Non-Self
Self vs. Non-Self
The Inflammatory Response
Leukocyte Migration: Transmigration and Emigration, Chemotaxis
Inflammatory Response in Action
Systemic Inflammation
Concepts in Cancer Immunology
Cancer Immunoediting
The Inflammatory Response
Inflammation
Cells of the Immune System
Immune Cell Development
Cells of the Immune System
Lymphoid Organs
Immunology of Cancer: Introduction
Immunology of Cancer: Introduction
Introduction: Basics of Immunology
Introduction: Basics of Immunology
Emerging Hypotheses on Treatment
Immunological Concepts: Monoclonal Antibodies
The Inflammatory Response
The Complement System: The Complement
The Complement System: The Compete Cascade
The Compl...
Traditional Immunosuppressive Therapies
Traditional Immunosuppressive Therapies
Introduction to Monoclonal Antibodies
Hybridoma Technology: Limitations
Traditional Immunosuppressive Therapies
Traditional Immunosuppressive Agents
Traditional Immunosuppressive Therapies
Corticosteroids: Gene Expression
Soluble Receptors and Other Cytokine Inhibitors
Soluble Receptors and Other Cytokine Inhibitors
Soluble Receptors and Other Cytokine Inhibitors
Abatacept
Clinical Applications of Monoclonal Antibodies
Clinical Applications of Monoclonal Antibodies: Learning Objectives
Clinical Applications of Monoclonal Antibodies
Biological Actions of mAbs
Clinical Applications of Monoclonal Antibodies
mAbs in Clinical Trials
Clinical Applications of Monoclonal Antibodies
New Antibody Formats
Traditional Immunosuppressive Therapies
Traditional Immunosuppressive Therapies
Traditional Immunosuppressive Agents
Traditional Immunosuppressive Therapies
Corticosteroids: Immediate Effect (Anti-Inflammatory)
Corticosteroids: Gene Expression
Cor...
Inflammatory Response in Action
Interactive Exercise: Inflammation
Interactive Exercise: The Inflammation Process
Interact...
The Inflammatory Response
Role of MHC in Antigen Presentation
The Inflammatory Response
The Complement System: Classical Pathway
T Cells and Cell-Mediated Immune Responses
Negative Selection
T Cells and Cell-Mediated Immune Responses
Anergy
Clinical Applications of Monoclonal Antibodies
Cancer Immunotherapy
Summary: Innate and Adaptive Immune Responses
Summary: Innate and Adaptive Immune Responses
Soluble Receptors and Other Cytokine Inhibitors
Cytokine Neutralizers
Cells of the Immune System
Lymph Node: T Cell Activation
The Inflammatory Response
Antigen Presentation: MHC/HLA
The Inflammatory Response
The Complement System: Inactive Proenzyme
T Cells and Cell-Mediated Immune Responses
Apoptosis
B Cells and Antibodies
Immunoglobulin Isotypes
Introduction to the Innate and Adaptive Immune Systems
The Immune System
Autoimmune Disease Examples
Autoimmune Disease Progression
Traditional Immunosuppressive Therapies
Corticosteroids: Adverse Effects
Clinical Applications of Monoclonal Antibodies
Receptor Cross-Linking
The Inflammatory Response
Role of MHC in Antigen Presentation
Antigen Presentation: APC and T Cell
The Inflammatory Response
Antigen Presentation: MHC/HLA (Association between HLA and Diseases)
The Inflammatory Response
Antigen Presentation: APC and T Cell
Cells of the Immune System
Lymph Node: B Cell Activation
B Cells and Humoral-Mediated Immune Responses
Isotypes
Adaptive Immune System Components
Adaptive Immunity
Adaptive Immune System Components
Intracellular Antigens
Adaptive Immune System Components
Extracellular Antigens
Hypersensitivity
Immediate Hypersensitivity (Type I)
The Inflammatory Response
The Complement System: The Compete Cascade
The Immune Response
The Skin Barrier
The Skin Barrier: Th1 and Th2 Responses
The Immune Response
The Skin Barrier: Th1 and Th2 Responses
The Innate Immune Response
Pattern Recognition Receptors (PRRs)
The Immune Response
How Innate and Adaptive Responses Work Together
Hypersensitivity
Hypersensitivity Diseases
Types of Hypersensitivity Responses
Immediate Hypersensitivity (...
Soluble Receptors and Other Cytokine Inhibitors
Abatacept
Mechanism of Action of Abatacept (Orencia)
Abatacept: A Soluble Fusion Protein
Cells of the Immune System
The Lymphatic System
Autoimmune Disease Examples
Interactivity: Autoimmune Diseases
Traditional Immunosuppressive Therapies
Corticosteroids: Gene Expression
Corticosteroids: Gene Expression (The Anti-Inflammatory Effect...
Cells of the Immune System
Lymph Node
Lymph Node: T Cell Activation
Lymph Node: B Cell Activation
Complement System in Action
The Complement Cascade
Activation of Complement
Interactive Exercise: Complement Cascade
Atopy vs. Allergy
Hypersensitivity Disorders
Introduction to the Innate and Adaptive Immune Systems
Interactive Exercise: Components and Actions of Adaptive and Innate Immunity
The Immune System
Concepts in Cancer Immunology
Cancer Immunosurveillance
T Cells and Cell-Mediated Immune Responses
Peripheral Tolerance
Peripheral Tolerance: Apoptosis in Clonal Deletion
Anergy
Suppre...
Clinical Applications of Monoclonal Antibodies
Receptor Cross-Linking
Inducing Complement-Mediated Cytotoxicity
Inducing Antibody-Depende...
T Cells and Cell-Mediated Immune Responses
Expression of T Cell Receptors (TCRs)
Apoptosis
Central Tolerance
Positive Selection
Adaptive Immune System Components
Adaptive Immunity
Intracellular Antigens
Extracellular Antigens
Interactive Exercise:...
Clinical Applications of Monoclonal Antibodies
Clinical Applications of Monoclonal Antibodies: Learning Objectives
Detection, Diagnosis, and M...
Soluble Receptors and Other Cytokine Inhibitors
Cytokine Inhibitors: Three Major Strategies
Introduction to Monoclonal Antibodies
Hybridoma Technology: Making a Monoclonal Antibody
Clinical Applications of Monoclonal Antibodies
Therapeutic mAbs: Examples of Approved Agents
Soluble Receptors and Other Cytokine Inhibitors
Soluble Receptors and Other Cytokine Inhibitors
Overview of Cytokine Therapy: Types of Cytokine...
Atopy vs. Allergy
Hypersensitivity Disorders: Gell-Coombs Classification
Soluble Receptors and Other Cytokine Inhibitors
Agents That Block Cytokine Receptors
Soluble Receptors and Other Cytokine Inhibitors
Soluble Receptor Therapies
Soluble Receptors and Other Cytokine Inhibitors
Enbrel (etanercept) Indications
Introduction to Monoclonal Antibodies
Four General Classes of mAb Therapies
Clinical Applications of Monoclonal Antibodies
A Closer Look At mABS Used as Therapies
Clinical Applications of Monoclonal Antibodies
Blocking the Actions of a Target Molecule
The Inflammatory Response
Antigen Presentation: MHC/HLA (Association between HLA and Diseases)
T Cells and Cell-Mediated Immune Responses
Central Tolerance
Traditional Immunosuppressive Therapies
Corticosteroids: Immediate Effect (Anti-Inflammatory)
Traditional Immunosuppressive Therapies
Corticosteroids: Gene Expression (Therapeutic Uses of Corticosteroids)
Soluble Receptors and Other Cytokine Inhibitors
Overview of Cytokine Therapy: Types of Cytokines
Soluble Receptors and Other Cytokine Inhibitors
Agents That Activate Anti-Inflammatory Pathways
Soluble Receptors and Other Cytokine Inhibitors
Abatacept: A Soluble Fusion Protein
Introduction to Monoclonal Antibodies
Early Antibody Therapy: Polyclonal Antibodies
Clinical Applications of Monoclonal Antibodies
Detection, Diagnosis, and Monitoring of Diseases and Disease-Related Molecules
Clinical Applications of Monoclonal Antibodies
Therapeutic mAbs: In the Treatment of Diseases
T Cells and Cell-Mediated Immune Responses
Peripheral Tolerance
T Cells and Cell-Mediated Immune Responses
T-Cell Specificity and Function
TH2 and TH2 Immune Responses
TH1 and TH2 Helper T Cells
TH2 and TH2 Immune Responses
TH2 Cells Coordinate Humoral Response
Soluble Receptors and Other Cytokine Inhibitors
Mechanism of Action of Abatacept (Orencia)
Clinical Applications of Monoclonal Antibodies
Inducing Complement-Mediated Cytotoxicity
Traditional Immunosuppressive Therapies
Corticosteroids: Gene Expression (The Anti-Inflammatory Effects of Corticosteroids)
Introduction to Monoclonal Antibodies
Naming Monoclonal Antibodies: Pali-vi-zu-mab
Clinical Applications of Monoclonal Antibodies
Inducing Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC)
T Cells and Cell-Mediated Immune Responses
Peripheral Tolerance
B Cells, Antibodies and Antibody-Mediated Immune Responses
BAFF and APRIL Receptor Signaling
B Cells and Humoral-Mediated Immune Responses
Immunoglobulin Effector Mechanisms
T Cells and Cell-Mediated Immune Responses
Positive Selection
T Cells and Cell-Mediated Immune Responses
T-Cell Activation - Costimulation
T Cells and Cell-Mediated Immune Responses
T-Cell Activation
Soluble Receptors and Other Cytokine Inhibitors
Soluble Receptor Therapies
Mechanism of Action of Enbrel (etanercept): Tumor Necrosis Factor In...
Innate and Adaptive (Acquired) Immune Systems
Self vs. Non-Self
T Cells and Cell-Mediated Responses
T Cell Lineage
Introduction to the Innate and Adaptive Immune Systems
Innate and Adaptive Immunity
TH2 and TH2 Immune Responses
CD4+ Helper T Cell Activation
TH2 and TH2 Immune Responses
TH1 Cells Coordinate Cell-Mediated Response
Hypersensitivity
Immune-Complex-Mediated Hypersensitivity (Type III)
Hypersensitivity
T Cell-Mediated Hypersensitivity (Type IV)
T Cells and Cell-Mediated Immune Responses
Peripheral Tolerance: Apoptosis in Clonal Deletion
B Cells and Humoral-Mediated Immune Responses
Overview of Antibody Production: B Cell Expression and Maturation
B Cells and Humoral-Mediated Immune Responses
Overview of Antibody Production: B Cell Clonal Expansion
B Cells and Humoral-Mediated Immune Responses
Immunoglobulins: IgG
B Cells and Humoral-Mediated Immune Responses
B Cells and Cytokine Production
Soluble Receptors and Other Cytokine Inhibitors
Cytokine Neutralizers
Cytokine Inhibitors: Three Major Strategies
Agents That Block Cytoki...
Adaptive Immune System Components
Activation of Humoral Immunity and Activation of Cell-Mediated Immunity
Cells of the Immune System
Overview of Cells of the Immune System
B Cells and Antibodies
Overview of B Cell Responses, Overview of Antibody Production
T Cells and Cell-Mediated Immune Responses
Expression of T Cell Receptors (TCRs)
TH2 and TH2 Immune Responses
TH1 and TH2 Helper T Cells
CD4+ Helper T Cell Activation
TH2 Cells Coordinate Humoral Resp...
Innate and Adaptive (Acquired) Immune Systems
Characteristics of Innate and Adaptive Immunity
The Inflammatory Response: Overview
Overview, Tissue Insult and Damage
Atopy vs. Allergy
Hypersensitivity Overview, Atopy versus Allergy
Introduction to Monoclonal Antibodies
Antibodies as Therapy
Early Antibody Therapy: Polyclonal Antibodies
Hybridoma Technology: ...
Innate and Adaptive (Acquired) Immune Systems
Characteristics of Innate and Adaptive Immunity
The Inflammatory Response: Antigen Processing and Presentation by Macrophages
The Inflammatory Response: Overview
The Inflammatory Response: Leukocyte Migration
The Inflammatory Response: Leukocyte Migration: Overview
Soluble Receptors and Other Cytokine Inhibitors
Mechanism of Action of Enbrel (etanercept): Tumor Necrosis Factor Inhibitor
Enbrel (etanercept)...
Additional concepts in MS Therapy
Immunologic Concepts
Genetic Concepts
Neurodegeneration
Neuroprotection
Remyelin...
T Cells and Cell-Mediated Immune Responses
Peripheral Tolerance
Peripheral Tolerance: Apoptosis in Clonal Deletion
B Cells and Humoral-Mediated Immune Responses
B-Cell Activation and Regulation: B-Cell Receptor (BCR)
B-Cell Maturation: B-Cell Precursors
T Cells and Cell-Mediated Immune Responses
Peripheral Tolerance: B Cell Peripheral Tolerance
T Cells and Cell-Mediated Immune Responses
Separation of the Autoreactive T Cell from the Host Antigen
B Cells, Antibodies and Antibody-Mediated Immune Responses
B Cell Production of Interleukin-10 (IL-10): Resolution of Autoimmune Disease Inflammatory Response
T Cells and Cell-Mediated Immune Responses
Suppression by T Regulatory Cells (Suppressor T Cells)
Innate and Adaptive (Acquired) Immune Systems
Innate and Adaptive (Acquired) Immune Systems: Overview
Soluble Receptors and Other Cytokine Inhibitors
Mechanism of Action of Enbrel (etanercept): Tumor Necrosis Factor Inhibitor
Soluble Receptors and Other Cytokine Inhibitors
The Rationale for Cytokine Therapy: Drugs That Act As Cytokines or Anticytokines
B Cells, Antibodies and Antibody-Mediated Immune Responses
B Cell Production of Interleukin-10 (IL-10): Downregulation the Active Inflammatory Response
T Cells and Cell-Mediated Immune Responses
Release from Bone Marrow and Migration to the Thymus
T Cells and Cell-Mediated Immune Responses
T-Cell Activation - T-Cell Receptor (TCR)
Innate and Adaptive (Acquired) Immune Systems
How Innate and Adaptive Responses Work Together
Pro- and Anti-Inflammatory Cytokines/Mediators
Overview, Proinflammatory versus Anti-Inflammatory Cytokines
B Cells, Antibodies and Antibody-Mediated Immune Responses
BAFF (B-cell Activating Factor) and APRIL (A Proliferation-Inducing Ligand)
B Cells, Antibodies and Antibody-Mediated Immune Responses
B-Cell Activation and Regulation: Antibody Production
B Cells, Antibodies and Antibody-Mediated Immune Responses
BAFF and APRIL: Effects on B Cell Maturation
B Cells and Humoral-Mediated Immune Responses
B-Cell Activation and Regulation: B-Cell Receptor (BCR)
B Cells and Humoral-Mediated Immune Responses
B-Cell Maturation: B-Cell Precursors
Pro- and Anti-Inflammatory Cytokines/Mediators
Signaling Pathways Regulating Production and Transcription of Inflammatory Mediators
B Cells, Antibodies and Antibody-Mediated Immune Responses
Antigen Processing and Presentation and MHC, Role of MHC in Antigen Presentation
Cancer Immunotherapy
Cancer Immunotherapy
Cancer Immunotherapy
Cancer Immunotherapy
Emerging Hypotheses on Treatment
Emerging Hypotheses on Treatment: Myelination-Targeted Antibodies
Cell Therapy
Human Stem ...
Innate Immunity
Innate Tumor Immunity: Macrophages
Cancer Immunotherapy
Adoptive T Cell Transfer
Cancer Immunotherapy
Cancer Vaccines
Suppression of Tumor Immunity
Overview of Immunosuppressive Mechanisms
Layers of the Skin: Epidermis
Epidermal Functions: Keratinocyte Differentiation
Emerging Hypotheses on Treatment
Immunological Concepts: Vaccines
Emerging Hypotheses on Treatment
Immunological Concepts: Summary
Innate Immunity
Innate Versus Adaptive Immunity in Anti-tumor Responses
Suppression of Tumor Immunity
Evasion of T Cell Recognition or Activation
Innate Immunity
Dendritic Cells and Anti-tumor Immunity
Innate Immunity
Innate Tumor Immunity: Natural Killer Cells
Adaptive T Cell Immunity
Induction of Adaptive T Cell Immunity
Adaptive T Cell Immunity
Cytotoxic T Cells (CTLs) and Tumor Cell Killing
Concepts in Cancer Immunology
Cancer Immunosurveillance
Concepts in Cancer Immunology
Cancer Immunoediting
Adaptive T Cell Immunity
Antigen Presentation and T Cell Activation
Adaptive T Cell Immunity
CD4+ T Helper Cells and Tumor Immunity
Emerging Hypotheses on Treatment
Immunological Concepts: Emerging Hypotheses on Treatment
Emerging Hypotheses on Treatment
Immunological Concepts: Oral Immune-Modulating Drugs
Basics of Immunology of Cancer
Cancer Vaccines: Types of Cancer Vaccines
Innate Immunity
Dendritic Cells and Antitumor Immunity
Innate Immunity
Innate Versus Adaptive Immunity in Antitumor Responses
Innate Immunity
Innate Tumor Immunity: Natural Killer Cells
Innate Immunity
Innate Tumor Immunity: Macrophages
Adaptive T Cell Immunity
Induction of Adaptive T Cell Immunity
Adaptive T Cell Immunity
Antigen Presentation and T Cell Activation
Adaptive T Cell Immunity
Cytotoxic T Cells (CTLs) and Tumor Cell Killing
Adaptive T Cell Immunity
CD4+ T Helper Cells and Tumor Immunity
Suppression of Tumor Immunity
Overview of Immunosuppressive Mechanisms
Suppression of Tumor Immunity
Evasion of T Cell Recognition or Activation
Cancer Immunotherapy: Adoptive T Cell Transfer
Adoptive T Cell Transfer
The Innate and Adaptive Immune System
Learning Objectives
Learning Objectives
Learning Objectives
Pathophysiology
Glial Cells, Click-on: Oligodendrocytes
Pathophysiology
Glial Cells, Click-on: Astrocytes
Pathophysiology
Glial Cells, Click-on: Microglia
Pathophysiology
Autoimmune Disease
Pathophysiology
Autoimmune Disease
Key Concepts in Autoimmunity: The Importance of Tolerance
The Birth and Early Education of Lymphocytes: Peripheral Tolerance (Separation of the Autoreactive T...
Hypersensitivity
Type IV Hypersensitivity Reaction Subgroups
Pathophysiology
Neurodegeneration
Pathophysiology
Glial Cells, Click-on: Oligodendrocytes
Glial Cells, Click-on: Astrocytes
Glial Cells, Cli...
Pathophysiology
Microglial Mediators of CNS Inflammation and Damage
Pathophysiology
Glial Cells, Click-on: Microglia
Microglial Mediators of CNS Inflammation and Damage
Current Therapies
Severe Relapses: Corticosteroids
Current Therapies
Severe Relapses: Therapeutic Plasma Exchange (TPE)
Additional concepts in MS Therapy
Genetic Concepts
Additional concepts in MS Therapy
Remyelinating Antibodies
Disease Overview
Patient Descriptions
Disease Overview
Etiology
Disease Overview
Classification of MS
Pathophysiology
Autoimmune Disease
Pathophysiology
Pathogenesis
Additional concepts in MS Therapy
Remyelination
Key Concepts in Autoimmunity: The Importance of Tolerance
The Birth and Early Education of Lymphocytes: Peripheral Tolerance (Anergy)
Autoimmune Disease Processes
Consequences of Autoimmune Diseases: Common Autoimmune Diseases
Autoimmune Diseases: Introduction
Epidemiology and Impact
Hypersensitivity
Autoimmune Diseases Classified as Hypersensitivity Reactions
Disease Overview
Relapses
Disease Overview
Disease Variability
Pathophysiology
Overview
Pathophysiology
Myelin-Reactive T Cells
Current Therapies
Hormonal Therapies
Current Therapies
Chemotherapeutic Agents
Current Therapies
Symptomatic Therapies - Severe Relapses
Key Concepts in Autoimmunity: The Importance of Tolerance
The Birth and Early Education of Lymphocytes: Central Tolerance
Key Concepts in Autoimmunity: The Importance of Tolerance
The Birth and Early Education of Lymphocytes: Central Tolerance (Negative Selection)
Introduction to Immunopathology
Hypersensitivity Disorders: Type II Antibody-Mediated
Introduction to Immunopathology
Hypersensitivity Disorders: Type III Immune Complex-Mediated
Key Concepts in Autoimmunity: The Importance of Tolerance
The Birth and Early Education of Lymphocytes: B Cell Peripheral Tolerance
Key Concepts in Autoimmunity: The Importance of Tolerance
The Birth and Early Education of Lymphocytes: Peripheral Tolerance (Apoptosis in Clonal Deletion)
Mechanisms of Autoimmune Disease: The Breakdown of Tolerance
The Breakdown of Tolerance: Molecular Mimicry
Autoimmune Disease Processes
The Etiology of Autoimmune Disease: Genetic Factors (Family and Population Studies)
Autoimmune Disease Processes
The Etiology of Autoimmune Disease: Lifestyle Factors
Autoimmune Disease Processes
Epitopes and Antigenic Determinants
Additional concepts in MS Therapy
Neurodegeneration
Key Concepts in Autoimmunity: The Importance of Tolerance
Key Terms and Concepts in Tolerance
Autoimmune Diseases: Introduction
The Breakdown of Tolerance: Molecular Mimicry
Hypersensitivity
Type II Reaction Examples
Autoimmune Diseases: Introduction
Mechanisms: Failure of Lymphocyte Suppression by Regulatory T Cells
Autoimmune Diseases: Introduction
Mechanisms: MHC Complex/Receptor Disorders
Autoimmune Diseases: Introduction
Mechanisms: Failure of Apoptosis Via Fas Receptors
Disease Overview
Progression
Disease Overview
Epidemiology
Pathophysiology
Autoimmune Disease: Overview
Pathophysiology
Demyelination
Current Therapies
Symptomatic Therapies - Symptom Reduction
Current Therapies
Intensive Immune Suppression For Non-Responders
Current Therapies
Cell Therapy
Additional concepts in MS Therapy
Neuroprotection
Autoimmune Disorders
Mechanisms: Failure of T Cell Suppression by Regulatory T Cells
Autoimmune Disorders
Mechanisms: MHC Complex/Receptor Disorders
Autoimmune Disorders
Mechanisms: Presence of Superantigens
Key Concepts in Autoimmunity: The Importance of Tolerance
The Birth and Early Education of Lymphocytes: Expression of T Cell Receptors (TCRs)
Key Concepts in Autoimmunity: The Importance of Tolerance
The Birth and Early Education of Lymphocytes: B Cell Central Tolerance
Introduction to Immunopathology
Immunopathologies: Clinical Consequences
Introduction to Immunopathology
Organ Transplant Rejection: How the Immune System Distinguishes between Self and Non-Self
Introduction to Immunopathology
Hypersensitivity Disorders
Introduction to Immunopathology
Autoimmune Diseases: The Spectrum of Attack
Introduction to Immunopathology
Organ Transplant Rejection: How the Immune System Distinguishes between Self and Non-Self
Introduction to Immunopathology
Immunodeficiency Syndromes
Key Concepts in Autoimmunity: The Importance of Tolerance
The Birth and Early Education of Lymphocytes: Tolerance (Some Thoughts...)
Mechanisms of Autoimmune Disease: The Breakdown of Tolerance
The Breakdown of Tolerance: MHC Complex/Receptor Disorders
Autoimmune Disease Processes
The Etiology of Autoimmune Disease: Genetic Factors (Risk)
Autoimmune Disease Processes
The Etiology of Autoimmune Disease: Genetic Factors (Introduction)
Autoimmune Disease Processes
Consequences of Autoimmune Diseases: Progression and Destruction in Autoimmune Disorders (Mechanisms...
Autoimmune Disease Processes
Consequences of Autoimmune Diseases: Progression and Destruction in Autoimmune Disorders (Epitope Sp...
HAE Diagnosis
Overview of HAE Diagnosis
Hypersensitivity
Limitations
Autoimmune Diseases: Introduction
The Breakdown of Tolerance
Autoimmune Diseases: Introduction
General Mechanism Underlying Autoimmune Disease
Introduction: Autoimmune Disorders and Hypersensitivity
Introduction: Autoimmune Disorders and Hypersensitivity - Immunopathologies
Introduction: Autoimmune Disorders and Hypersensitivity
Introduction: Autoimmune Disorders and Hypersensitivity - Causes and Statistics
Hypersensitivity
Introduction: Hypersensitivity
Hypersensitivity
Gell-Coombs Classification
Hypersensitivity
Hypersensitivity Disorders: Type III Immune Complex-Mediated
Autoimmune Diseases: Introduction
Mechanisms: Loss of T Cell Anergy
Autoimmune Diseases: Introduction
Mechanisms: Release of Sequestered Antigens
Autoimmune Diseases: Introduction
Mechanisms: Presence of Superantigens
Mechanisms of Select Autoimmune Disorders
Systemic Lupus Erythematosus: Failure of Vital Organs
Mechanisms of Select Autoimmune Disorders
Rheumatoid Arthritis: TH17
Mechanisms of Select Autoimmune Disorders
Psoriasis: Upregulated Cytokines
Mechanisms of Select Autoimmune Disorders
Psoriasis Arthritis: Pain and Swelling in Joints
Mechanisms of Select Autoimmune Disorders
Ankylosing Spondylitis: Enthesis and Kyphosis
Mechanisms of Select Autoimmune Disorders
Ankylosing Spondylitis: Heredity
Mechanisms of Select Autoimmune Disorders
Multiple Sclerosis: Demyelination
Disease Overview
Definition of Multiple Sclerosis
Disease Overview
Clinical Presentation
Pathophysiology
T Cell Initiation of MS Blood Brain Barrier
Pathophysiology
T Cell Initiation of MS
Pathophysiology
Plaques - Pathology
Additional concepts in MS Therapy
Cell Transplantation
Autoimmune Disorders
Mechanisms: Release of Sequestered Antigens
Autoimmune Disorders
Mechanisms: Failure of Apoptosis Via Fas Receptors
Introduction
Introduction: Autoimmune Diseases
Hypersensitivity
Hypersensitivity: Hypersensitivity Disorders
Mechanisms of Select Autoimmune Disorders
Systemic Lupus Erythematosus
Biologic DMARDs
Introduction to Biologic Disease-Modifying Antirheumatic Drugs (DMARDs)
Key Concepts in Autoimmunity: The Importance of Tolerance
The Birth and Early Education of Lymphocytes
Key Concepts in Autoimmunity: The Importance of Tolerance
The Birth and Early Education of Lymphocytes: Deletion of Cells that Lack T Cell Receptors
Key Concepts in Autoimmunity: The Importance of Tolerance
The Birth and Early Education of Lymphocytes: Central Tolerance (Positive Selection)
Introduction to Immunopathology
Immunopathologies: Categories
Introduction to Immunopathology
Hypersensitivity Disorders: Type I Immediate Hypersensitivity
Introduction to Immunopathology
Hypersensitivity Disorders: Type IV T-Cell-Mediated (Delayed)
Introduction to Immunopathology
Autoimmune Diseases: General Mechanism Underlying Autoimmune Disease
Introduction to Immunopathology
Autoimmune Diseases
Introduction to Immunopathology
Organ Transplant Rejection: HLA Typing for Transplant
Introduction to Immunopathology
Organ Transplant Rejection: Introduction
Introduction to Immunopathology
Organ Transplant Rejection: Host-Versus-Graft Disease (HVGD) and Graft-Versus-Host Disease (GVHD)
Key Concepts in Autoimmunity: The Importance of Tolerance
The Birth and Early Education of Lymphocytes: Peripheral Tolerance
Key Concepts in Autoimmunity: The Importance of Tolerance
The Birth and Early Education of Lymphocytes: Peripheral Tolerance (Peripheral mechanisms)
Key Concepts in Autoimmunity: The Importance of Tolerance
The Birth and Early Education of Lymphocytes: Peripheral Tolerance (Suppression by T Regulatory Cell...
Mechanisms of Autoimmune Disease: The Breakdown of Tolerance
Mechanisms of Autoimmune Disease: The Breakdown of Tolerance
Mechanisms of Autoimmune Disease: The Breakdown of Tolerance
The Breakdown of Tolerance: Loss of T Cell Anergy
Mechanisms of Autoimmune Disease: The Breakdown of Tolerance
The Breakdown of Tolerance: Failure of T Cell Suppression by Regulatory T Cells
Mechanisms of Autoimmune Disease: The Breakdown of Tolerance
The Breakdown of Tolerance: Release of Sequestered Antigens
Mechanisms of Autoimmune Disease: The Breakdown of Tolerance
The Breakdown of Tolerance: Presence of Superantigens
Mechanisms of Autoimmune Disease: The Breakdown of Tolerance
The Breakdown of Tolerance: Failure of Apoptosis via Fas Receptors
Autoimmune Disease Processes
The Etiology of Autoimmune Disease
Autoimmune Disease Processes
The Etiology of Autoimmune Disease: Genetic Factors (Chromosomal Evidence: The Importance of HLA)
Autoimmune Disease Processes
The Etiology of Autoimmune Disease: Hormonal Factors
Autoimmune Disease Processes
The Etiology of Autoimmune Disease: Environmental Factors
Autoimmune Disease Processes
The Etiology of Autoimmune Disease: Environmental Factors (Non-Infectious Agents)
Autoimmune Disease Processes
Consequences of Autoimmune Diseases: Progression and Destruction in Autoimmune Disorders (Mechanisms...
Autoimmune Disease Processes
Consequences of Autoimmune Diseases: The Natural History of Autoimmune Disorders
Key Concepts in Autoimmunity: The Importance of Tolerance
The Birth and Early Education of Lymphocytes: Peripheral Tolerance
The Birth and Early Educatio...
Hypersensitivity
Type I Hypersensitivity Reaction: Immediate Hypersensitivity
Hypersensitivity
Hypersensitivity Disorders: Type 1 Immediate Hypersensitivity
Hypersensitivity
Type II Hypersensitivity Reaction (Antibody Mediated)
Mechanisms of Select Autoimmune Disorders
Systemic Lupus Erythematosus: Symptoms and Risk
Mechanisms of Select Autoimmune Disorders
Systemic Lupus Erythematosus: Multisymptom Disease
Mechanisms of Select Autoimmune Disorders
Psoriasis Arthritis: Psoriatic Spondylitis
Disease Overview
Prognosis
Pathophysiology
B Cells and Autoantibodies in Disease Progression
Current Therapies
Goals of Disease Modifying Therapy (DMT)
Current Therapies
Rationale for Early Treatment
Autoimmune Disorders
Mechanisms: The Breakdown of Tolerance Molecular Mimicry
Autoimmune Disorders
Mechanisms: Loss of T Cell Anergy
Autoimmune Disorders
Introduction: Autoimmune Disorders: Affects Almost Any Part of the Body
Autoimmune Disorders
Introduction: Autoimmune Disorders: Statistics
Mechanisms of Select Autoimmune Disorders
Rheumatoid Arthritis: Early Stages of RA
Mechanisms of Select Autoimmune Disorders
Multiple Sclerosis
Mechanisms of Select Autoimmune Disorders
Multiple Sclerosis: Axon Damage
Autoimmune Disease Processes
The Breakdown of Tolerance: The Hidden Role of Cryptic Epitopes
Autoimmune Disease Processes
Consequences of Autoimmune Diseases: TNF-α In Autoimmune Disease: Potential Harm OR Benefit?
Key Concepts in Autoimmunity: The Importance of Tolerance
The Birth and Early Education of Lymphocytes: Expression of T Cell Receptors (TCRs)
The Birth a...
Hypersensitivity
Type II Hypersensitivity Reaction (Antibody Mediated)
Type II Reaction Examples
Hypersensitivity
Hypersensitivity Disorders: Type IV T-Cell-Mediated (Delayed)
Mechanisms of Select Autoimmune Disorders
Rheumatoid Arthritis: Patients
Mechanisms of Select Autoimmune Disorders
Psoriasis: Psoriatic keratinocytes Pathway
Introduction: Multiple Sclerosis
Introduction: Hypersensitivity Reactions
Mechanisms of Select Autoimmune Disorders
Psoriasis
Mechanisms of Select Autoimmune Disorders
Psoriasis Arthritis
Mechanisms of Select Autoimmune Disorders
Ankylosing Spondylitis
Mechanisms of Select Autoimmune Disorders
Systemic Lupus Erythematosus (SLE)
Key Concepts in Autoimmunity: The Importance of Tolerance
The Birth and Early Education of Lymphocytes: Release from Bone Marrow and Migration to the Thymus
Key Concepts in Autoimmunity: The Importance of Tolerance
The Birth and Early Education of Lymphocytes: Central Tolerance
The Birth and Early Education o...
Introduction to Immunopathology
Immunopathologies: Clinical Consequences
Immunopathologies: Categories
Introduction to Immunopathology
Autoimmune Diseases: Epidemiology and Impact
Autoimmune Disease Processes
The Etiology of Autoimmune Disease: Environmental Factors (Infectious Agents)
Autoimmune Disease Processes
Epitopes and Antigenic Determinants
The Breakdown of Tolerance: The Hidden Role of Cryptic Epit...
Hypersensitivity
Type IV Hypersensitivity Reaction Subgroups
Gell-Coombs Classification
Type I Hypersensiti...
Pathophysiology
Pathophysiological Mechanisms
Autoimmune Diseases: Introduction
Autoimmune Diseases: Introduction
Diagnosis of SLE
1997 ACR Diagnostic Criteria
Autoimmune Diseases: Introduction
Autoimmune Diseases: Introduction
Epidemiology and Impact
Hypersensitivity
Type I Hypersensitivity Reaction: Immediate Hypersensitivity
Hypersensitivity Disorders: Type 1...
Mechanisms of Select Autoimmune Disorders
Rheumatoid Arthritis: Cell Migration, Neoangiogenesis, and Early Stages
Mechanisms of Select Autoimmune Disorders
Multiple Sclerosis: Molecular Mimicry
Mechanisms of Select Autoimmune Disorders
Multiple Sclerosis: T Cells, B Cells, Axon Damage
Pathophysiology
Plaques - Pathology
Plaques - Histology
Pathophysiology
Plaques - Histology
Mechanisms of Select Autoimmune Disorders
Rheumatoid Arthritis
Key Concepts in Autoimmunity: The Importance of Tolerance
The Birth and Early Education of Lymphocytes: Expression of T Cell Receptors (TCRs)
The Birth a...
Introduction to Immunopathology
Organ Transplant Rejection: Class I MHC and Class II MHC Proteins
Key Concepts in Autoimmunity: The Importance of Tolerance
The Birth and Early Education of Lymphocytes: B Cell Central Tolerance
The Birth and Early Educ...
Introduction to Immunopathology
Hypersensitivity Disorders
Hypersensitivity Disorders: Type I Immediate Hypersensitivity
H...
Autoimmune Disease Processes
The Etiology of Autoimmune Disease: Genetic Factors (Risk)
The Etiology of Autoimmune Disease: ...
Autoimmune Disease Processes
Consequences of Autoimmune Diseases: Progression and Destruction in Autoimmune Disorders (Mechanisms...
Autoimmune Disease Processes
Consequences of Autoimmune Diseases: Progression and Destruction in Autoimmune Disorders (Mechanisms...
Autoimmune Disease Processes
Consequences of Autoimmune Diseases: Progression and Destruction in Autoimmune Disorders (Mechanisms...
Immunogenicity
Immunogenicity: Introduction
Soft Tissue Sarcomas (STSs)
Anatomy and Pathophysiology: Mechanisms of Disease Development and Progression
Pathophysiology
Overview
T Cell Initiation of MS Blood Brain Barrier
B Cells and Autoantibodies in Diseas...
Introduction to Immunopathology
Autoimmune Diseases: Epidemiology and Impact
Autoimmune Diseases: General Mechanism Underlying ...
Autoimmune Disease Processes
The Etiology of Autoimmune Disease: Environmental Factors (Infectious Agents)
The Etiology of A...
Autoimmune Disease Processes
Consequences of Autoimmune Diseases: Progression and Destruction in Autoimmune Disorders (Mechanisms...
Advancing Technologies
Biomarkers: Neurodegenerative Biomarkers
Proteins
Protein Modifications: Pegylation
Autoimmune Diseases: Introduction
The Breakdown of Tolerance
The Breakdown of Tolerance: Molecular Mimicry
Mechanisms: Loss ...
Disease Overview
Definition of Multiple Sclerosis
Prognosis
Clinical Presentation
Patient Descriptions...
Mechanisms of Autoimmune Disease: The Breakdown of Tolerance
Mechanisms of Autoimmune Disease: The Breakdown of Tolerance
The Breakdown of Tolerance: Molecu...
Autoimmune Disease Processes
The Etiology of Autoimmune Disease
The Etiology of Autoimmune Disease: Genetic Factors (Risk)
Autoimmune Diseases: Introduction
General Mechanism Underlying Autoimmune Disease
The Breakdown of Tolerance
The Breakdown o...
Current Therapies
Goals of Disease Modifying Therapy (DMT)
Symptomatic Therapies - Symptom Reduction
Hormona...
Autoimmune Disorders
Mechanisms: The Breakdown of Tolerance Molecular Mimicry
Mechanisms: Loss of T Cell Anergy
Introduction to Immunopathology
Organ Transplant Rejection: Class I MHC and Class II MHC Proteins
Organ Transplant Rejection: H...
Mechanisms of Autoimmune Disease: The Breakdown of Tolerance
Mechanisms of Autoimmune Disease: The Breakdown of Tolerance
The Breakdown of Tolerance: Molecu...
Autoimmune Disease Processes
The Etiology of Autoimmune Disease
The Etiology of Autoimmune Disease: Genetic Factors (Risk)
HCV Infection
Natural History of HCV Infection
Natural History of Type 1 Diabetes
Natural History of Type 1 Diabetes
Summary: Diabetes: Type 1 Pathophysiology
Pathophysiology of Type 1 Diabetes
Medical Device Regulation
Regulatory Classifications: Investigational Device Exemption (IDE)
Biosimilars
Example of a Biosimilar Not Approved by the EMA
Basaglar T1DM: Summary
Pathophysiology of Type 1 Diabetes
Liver Diseases Overview
Primary Sclerosing Cholangitis (PSC)
Biological Products
Biologics and Protein Therapeutics
Regulation of Biosimilars
Quality and Ingredient Requirements
Country-Specific Definitions and Regulatory Guidelines
European Medicines Agency (EMA)
Introduction to Immunopathology
Organ Transplant Rejection: Class I MHC and Class II MHC Proteins
Organ Transplant Rejection: H...
Regulation of Biosimilars
Manufacturing Requirements
Biopharmaceuticals/Biologics
Biologics: Specific Subclass of Drug
HCV Infection
Risk Factors Associated With Transmission of HCV
Impact of the Epidemic
HCV Infection
Gaucher Disease: Overview
Clinical Manifestations
Immunogenicity
Immunogenicity: Introduction
Factors Influencing Immunogenicity
Factors Influencing Immuno...
Management of C1-INH-HAE
Overview of Management of C1-INH-HAE
Advancing Technologies
Biomarkers: Disease Process-Specific Biomarkers
Biomarkers: Inflammation Biomarkers
Biomar...
Proteins
Types of Cytokines
Protein Modifications
Manufacturing Biologic Proteins
Agonist
Hereditary Angioedema: Historical Perspective
Hereditary Angioedema: Historical Perspective
Classification Review and Diagnostic Considerations
Classification Review and Diagnostic Considerations
Typical Course of Plaque Psoriasis
Onset, Episodes, Flare-Ups, Triggers
Complications and Comorbidities of Psoriasis
Typical Course of Plaque Psoriasis
Complications and Comorbidities of Psoriasis
Hereditary Angioedema: Definitions
Hereditary Angioedema: Definitions
Currently Approved Therapies: Tysabri
Tysabri
Pathophysiology
Immunopathophysiology: T Cell Initiation of MS
Country-Specific Definitions and Regulatory Guidelines
Japanese Ministry of Health, Labour and Welfare (MHLW)
Pathophysiology
Immunopathophysiology: Myelin-Reactive T Cells
Immunopathophysiology: T Cell Initiation of MS -...
Inhaled Corticosteroids (ICS)
Important Features of Corticosteroid Therapy in the Treatment of Asthma
Corticosteroids: Cellul...
Inhaled Corticosteroids (ICS)
Important Features of Corticosteroid Therapy in the Treatment of Asthma
Inhaled Corticosteroids (ICS)
How Does Asthma Affect Respiration?
Inhaled Corticosteroids (ICS)
Asthma: Inflammation and Bronchospasm
Inhaled Corticosteroids (ICS)
Important Features of Corticosteroid Therapy in the Treatment of Asthma
Inhaled Corticosteroids (ICS)
Important Features of Corticosteroid Therapy in the Treatment of Asthma
Inhaled Corticosteroids (ICS)
Important Features of Corticosteroid Therapy in the Treatment of Asthma
Inhaled Corticosteroids (ICS)
Important Features of Corticosteroid Therapy in the Treatment of Asthma
Inhaled Corticosteroids (ICS)
Corticosteroids: Cellular Mechanisms of Action
Inhaled Corticosteroids (ICS)
Corticosteroids: Mechanisms of Action
Leukotriene Modifiers
Leukotriene Modifiers
Leukotriene Chemical Structure
Leukotriene Production
Leukotrie...
Long-Acting Beta 2 Adrenergic Agonists
Normal Anatomy and Physiology
Pathophysiology of Asthma
Beta 2 Adrenergic Receptor Mechani...
Inhaled Corticosteroids (ICS)
Corticosteroids
Inhaled Corticosteroids (ICS)
Normal Respiration
Inhaled Corticosteroids (ICS)
How Does Asthma Affect Respiration?
Asthma: Inflammation and Bronchospasm
Inhaled Corticosteroids (ICS)
Corticosteroid Mechanism of Action
Leukotriene Modifiers
Leukotriene Modifiers
Leukotriene Modifiers
Leukotriene Chemical Structure
Leukotriene Modifiers
Leukotriene Production
Leukotriene Modifiers
Leukotriene Receptors
Leukotriene Modifiers
Leukotriene Receptors
Leukotriene Modifiers
Inflammatory Events Initiated by Leukotriene Receptors
Leukotriene Modifiers
Leukotriene Modifiers
Leukotriene Modifiers
Leukotriene Receptors
Long-Acting Beta 2 Adrenergic Agonists
Normal Anatomy and Physiology
Long-Acting Beta 2 Adrenergic Agonists
Normal Anatomy and Physiology
Long-Acting Beta 2 Adrenergic Agonists
Normal Anatomy and Physiology
Long-Acting Beta 2 Adrenergic Agonists
Pathophysiology of Asthma
Long-Acting Beta 2 Adrenergic Agonists
Pathophysiology of Asthma
Long-Acting Beta 2 Adrenergic Agonists
Pathophysiology of Asthma
Long-Acting Beta 2 Adrenergic Agonists
Pathophysiology of Asthma
Long-Acting Beta 2 Adrenergic Agonists
Beta 2 Adrenergic Receptor Mechanism of Action
Long-Acting Beta 2 Adrenergic Agonists
Beta 2 Adrenergic Receptor Mechanism of Action
Long-Acting Beta 2 Adrenergic Agonists
Beta 2 Adrenergic Receptor Mechanism of Action
Long-Acting Beta 2 Adrenergic Agonists
Beta 2 Adrenergic Receptor Mechanism of Action
Long-Acting Beta 2 Adrenergic Agonists
Beta 2 Adrenergic Receptor Mechanism of Action
Long-Acting Beta 2 Adrenergic Agonists
Beta 2 Adrenergic Receptor Mechanism of Action
Steroids
SLE Treatments: Glucocorticoids
Steroids
Treatments: Steroids
Introduction: Psoriasis Treatment
Introduction: Psoriasis Treatment
Steroids
Glucocorticoids: Mode of Action
The Anti-Inflammatory Effects of Corticosteroids
Glucocort...
Steroids
Glucocorticoids: Mode of Action
Steroids
The Anti-Inflammatory Effects of Corticosteroids
Steroids
Glucocorticoids: Side Effects
Forms of Lupus
Drug-induced Lupus
Forms of Lupus
Cutaneous Lupus Erythematosus (CLE)
Lupus Introduction
Lupus Systemic Lupus Erythematosus (SLE)
Lupus Introduction
Historical Context
Lupus Introduction
Lupus Systemic Lupus Erythematosus (SLE)
Historical Context
Symptoms of Lupus
Lupus Introduction
Symptoms of Lupus
Forms of Lupus
Forms of Lupus
Forms of Lupus
Cutaneous Lupus Erythematosus (CLE)
Forms of Lupus
Systemic Lupus Erythematosus
Forms of Lupus
Systemic Lupus Erythematosus
Lupus Pathogenesis
Autoimmune Mechanisms
Forms of Lupus
Neonatal Lupus
Lupus Pathogenesis
Dysfunctional Response of the Immune System
Lupus Pathogenesis
Dysfunctional Response of the Immune System: Role of BAFF and Cytokines
Lupus Pathogenesis
Dysfunctional Response of the Immune System
Lupus Pathogenesis
Nephritis
Summary: Pathophysiology of Lupus
Summary: Pathophysiology of Lupus
Lupus Pathogenesis
Nephritis
Vasculitis
Lupus Pathogenesis
Vasculitis
Diagnosis of SLE
Hallmark Autoantibodies: Antiphospholipid Antibodies
Hallmark Autoantibodies: Rheumatoid Factor...
Diagnosis of SLE
Hematological Abnormalities
Hallmark Antibodies
Typical Clinical Course
Course of Disease
Epidemiology
Epidemiology of Systemic Lupus Erythematosus (SLE): Mortality and Survival
Epidemiology of Syst...
Epidemiology
Epidemiology of Systemic Lupus Erythematosus (SLE): Mortality and Survival
Epidemiology
Epidemiology of Systemic Lupus Erythematosus (SLE): Gender and Age of Onset
Epidemiology
Epidemiology of Systemic Lupus Erythematosus (SLE): Gender and Age of Onset
Epidemiology
Epidemiology of Systemic Lupus Erythematosus (SLE): Gender
Epidemiology
Epidemiology of Systemic Lupus Erythematosus (SLE): Geographical and Racial Distribution
Epidemiology
Epidemiology of Systemic Lupus Erythematosus (SLE): Geographical and Racial Distribution
Epidem...
Epidemiology
Epidemiology of Systemic Lupus Erythematosus (SLE): Prevalence and Incidence
Introduction: Clinical Presentation of Lupus
Introduction: Clinical Presentation of Lupus
Epidemiology
Epidemiology of Systemic Lupus Erythematosus (SLE): Cutaneous Lupus Erythematosus (CLE)
Typical Clinical Course
Clinical Features/Presentation
Epidemiology
Epidemiology of Systemic Lupus Erythematosus (SLE): Lupus Nephritis (LN)
Typical Clinical Course
Patient Scenario: SLE
Diagnosis of SLE
Hematological Abnormalities
Diagnosis of SLE
Hallmark Antibodies
Diagnosis of SLE
Hallmark Autoantibodies: Antiphospholipid Antibodies
Typical Clinical Course
Symptoms of SLE
Typical Clinical Course
Organ Systems Involved
Diagnosis of SLE
Hallmark Autoantibodies: Rheumatoid Factor (RF)
Diagnosis of SLE
1997 ACR Diagnostic Criteria: Limitations- Clinical Practice
Diagnosis of SLE
Characteristics of Patients with Mild SLE
Diagnosis of SLE
Standard Measures of Disease Activity Used in Clinical Trials: SLAM
Diagnosis of SLE
Standard Measures of Disease Activity Used in Clinical Trials: ECLAM
Diagnosis of SLE
Standard Measures of Disease Activity Used in Clinical Trials
Diagnosis of SLE
Standard Measures of Disease Activity Used in Clinical Trials: SLAM
Standard Measures of Diseas...
Diagnosis of SLE
Standard Measures of Disease Activity Used in Clinical Trials: SLEDAI
Diagnosis of SLE
Standard Measures of Disease Activity Used in Clinical Trials: SELENA-SLEDAI
Diagnosis of SLE
Standard Measures of Disease Activity Used in Clinical Trials: SLEDAI-2K
Standard Measures of D...
Diagnosis of SLE
Standard Measures of Disease Activity Used in Clinical Trials: SLEDAI-2K
Diagnosis of SLE
Differential Diagnosis
Lifelong Monitoring of SLE Patients
Diagnosis of SLE
Standard Measures of Disease Activity Used in Clinical Trials: SLICC/ACR Damage Index for SLE
Diagnosis of SLE
Standard Measures of Disease Activity Used in Clinical Trials: SLE Responder Index (SRI-4)
Diagnosis of SLE
Differential Diagnosis
Diagnosis of SLE
Lifelong Monitoring of SLE Patients
Complications/Comorbidities of SLE
Lupus Nephritis: 1974 WHO Classification of Lupus Nephritis (LN)
Complications/Comorbidities of SLE
Lupus Nephritis and End-Stage Renal Failure
Complications/Comorbidities of SLE
Lupus Nephritis: 1974 WHO Classification of Lupus Nephritis (LN)
Lupus Nephritis and End-Stage ...
Complications/Comorbidities of SLE
Complications/Comorbidities of SLE
Complications/Comorbidities of SLE
Lupus Nephritis: End-Stage Renal Failure
Complications/Comorbidities of SLE
Cardiovascular Disease (CVD)
Overlapping Diseases
SLE and Secondary Sjogren's Syndrome
SLE and Scleroderma
SLE and Overlapping Diseases ...
Complications/Comorbidities of SLE
Lupus Nephritis: 2003 ISN-RPS Classification of Lupus Nephritis (LN)
Complications/Comorbidities of SLE
Osteoporosis
Osteonecrosis (ON)
Complications/Comorbidities of SLE
Osteoporosis
Complications/Comorbidities of SLE
Shrinking Lung Syndrome
Complications/Comorbidities of SLE
Quality of Life in SLE
Overlapping Diseases
SLE and Secondary Sjogren's Syndrome
Overlapping Diseases
SLE and Scleroderma
Complications/Comorbidities of SLE
Neuropsychiatric and Neurocognitive Dysfunction
Complications/Comorbidities of SLE
Quality of Life in SLE
Complications/Comorbidities of SLE
Quality of Life in SLE
SLE Treatments: Immunosuppressants
Mycophenolate mofetil: Side Effects
SLE Treatments: Immunosuppressants
Mycophenolate mofetil: Efficacy in Lupus Nephritis
SLE Treatments: Immunosuppressants
Immunosuppressants: Azathioprine (AZA)
Azathioprine (AZA): Side Effects
SLE Treatments: Immunosuppressants
Immunosuppressants: Azathioprine (AZA)
SLE Treatments: Immunosuppressants
Azathioprine (AZA): Side Effects
SLE Treatments: Immunosuppressants
Mycophenolate mofetil: Side Effects
Mycophenolate mofetil: Efficacy in Lupus Nephritis
Imm...
SLE Treatments: Immunosuppressants
Immunosuppressants: Mycophenolate mofetil
SLE Treatments: Immunosuppressants
Cyclophosphamide (CTX) Limited by Significant Toxicity
SLE Treatments: Immunosuppressants
Cyclophosphamide (CTX) Limited by Significant Toxicity
Immunosuppressants: Cyclophosphamide (CT...
SLE Treatments: Immunosuppressants
Immunosuppressants: Cyclophosphamide (CTX)
SLE Treatments: Antimalarials
Antimalarials: Efficacy
SLE Treatments: Antimalarials
Antimalarials: Side Effects
SLE Treatments: Antimalarials
Antimalarials: Indicated for Use in SLE
SLE Treatments: Antimalarials
Antimalarials: Mode of Action
Steroids
Glucocorticoids: Efficacy
SLE Treatments: NSAIDs
NSAIDs in SLE
SLE Treatments: NSAIDs
Main Types of NSAIDs
SLE Treatments: NSAIDs
Mode of Action
SLE Treatments: NSAIDs
Indicated for Use in SLE
Therapies: Approved and Off-Label
Therapies: Approved
Therapies: Off-Label
Therapeutic Approach: Guidelines
Management of Lupus Nephritis (LN)
Therapies: Approved and Off-Label
Therapies: Approved
Therapies: Approved and Off-Label
Therapies: Off-Label
Therapeutic Approach: Guidelines
Management of Antiphospholipid Syndrome (APS) in SLE
Therapeutic Approach: Guidelines
Management of Lupus Nephritis (LN)
Management of Antiphospholipid Syndrome (APS) in SLE
Th...
Therapeutic Approach: Guidelines
Therapeutic Approach: Guidelines
Therapeutic Approach: Guidelines
Management of SLE: Treatment
SLE Treatments: NSAIDs
Main Types of NSAIDs
Mode of Action
Indicated for Use in SLE
Therapeutic Approach: Guidelines
Management of SLE: Adjunct Therapy
Therapeutic Approach: Guidelines
Management of Neuropsychiatric Systemic Lupus Erythematosus (NPSLE)
Therapeutic Approach: Guidelines
Management of Pregnancy in SLE
Introduction: Lupus Treatments
Treatment of SLE
Goals of Therapy
Goals of SLE Therapy
Lupus Risk Factors
Genetics
Lupus Pathogenesis
Autoimmune Mechanisms
Dysfunctional Response of the Immune System
Lupus Risk Factors
Genetics
Combination of Genetics and Environment
Lupus Risk Factors
Combination of Genetics and Environment
Lupus Risk Factors
Environment
Lupus Risk Factors
Triggers
Lupus Pathogenesis
Dysfunctional Response of the Immune System: Role of BAFF and Cytokines
Lupus Pathogenesis
Dysfunctional Response of the Immune System: B Cells and T Cells
Autoantibodies in SLE
Lupus Pathogenesis
Dysfunctional Response of the Immune System: B Cells and T Cells
Lupus Pathogenesis
Autoantibodies in SLE
Lupus Pathogenesis
Pathogenic Autoantibodies in SLE
Diagnosis of SLE
Hallmark Autoantibodies
Diagnosis of SLE
Hallmark Autoantibodies: Antibodies Directed Against Ribonucleoproteins
Diagnosis of SLE
Hallmark Autoantibodies: Complement
Diagnosis of SLE
1997 ACR Diagnostic Criteria: Limitations- Clinical Practice
Characteristics of Patients with M...
Diagnosis of SLE
1997 ACR Diagnostic Criteria: Limitations- Clinical Studies
Diagnosis of SLE
Standard Measures of Disease Activity Used in Clinical Trials: BILAG, SLAM, ECLAM
Complications/Comorbidities of SLE
Osteonecrosis (ON)
Overlapping Diseases
SLE and Overlapping Diseases (Overlap Syndrome)
Overlapping Diseases
SLE and Rheumatoid Arthritis (RA)
Overlapping Diseases
SLE and Myositis
Overlapping Diseases
SLE and Antiphospholipid Syndrome (APS)
Overlapping Diseases
Mixed Connective Tissue Disease
SLE Treatments: Immunosuppressants
Immunosuppressants: Methotrexate (MTX)
Methotrexate (MTX): Mode of Action
Methotrexate (MT...
SLE Treatments: Immunosuppressants
Immunosuppressants: Methotrexate (MTX)
SLE Treatments: Immunosuppressants
Methotrexate (MTX): Mode of Action
SLE Treatments: Immunosuppressants
Methotrexate (MTX): Side Effects
SLE Treatments: Immunosuppressants
Immunosuppressants: Cyclosporine A (CsA)
Cyclosporine A (CsA): Mode of Action
Cyclosporine...
SLE Treatments: Immunosuppressants
Immunosuppressants: Cyclosporine A (CsA)
SLE Treatments: Immunosuppressants
Cyclosporine A (CsA): Mode of Action
SLE Treatments: Immunosuppressants
Cyclosporine A (CsA): Efficacy in Proliferative LN
SLE Treatments: Immunosuppressants
Cyclosporine A (CsA): Side Effects
SLE Treatments: Immunosuppressants
Immunosuppressants: IVIg
IVIg: Case Reports
IVIg: Side Effects
SLE Treatments: Immunosuppressants
Immunosuppressants: IVIg
SLE Treatments: Immunosuppressants
IVIg: Case Reports
SLE Treatments: Immunosuppressants
IVIg: Side Effects
SLE Treatments: Immunosuppressants
Immunosuppressants: Leflunomide
SLE Treatments: Immunosuppressants
Immunosuppressants: Tacrolimus
SLE Treatments: Immunosuppressants
Immunosuppressants: Sirolimus
SLE Treatments: MAbs/Biologics
Monoclonal Antibodies (MAbs) Biologics: Introduction
SLE Treatments: MAbs/Biologics
Belimumab
Belimumab: Indication
Belimumab: Mechanism of Action
Belimumab: Dosage and ...
SLE Treatments: MAbs/Biologics
Belimumab
SLE Treatments: MAbs/Biologics
Belimumab: Indication
SLE Treatments: MAbs/Biologics
Belimumab: Mechanism of Action
SLE Treatments: MAbs/Biologics
Belimumab: Dosage and Administration
SLE Treatments: MAbs/Biologics
Belimumab: Clinical Trials
Belimumab: Clinical Trial 1(Phase II)
Belimumab Clinical Trials...
SLE Treatments: MAbs/Biologics
Belimumab: Clinical Trials
SLE Treatments: MAbs/Biologics
Belimumab: Clinical Trial 1(Phase II)
SLE Treatments: MAbs/Biologics
Belimumab Clinical Trials 2 and 3: Trial Design
Belimumab Clinical Trials 2 and 3: Study Endpo...
SLE Treatments: MAbs/Biologics
Belimumab Clinical Trials 2 and 3: Trial Design
SLE Treatments: MAbs/Biologics
Belimumab Clinical Trials 2 and 3: Trial Design
SLE Treatments: MAbs/Biologics
Belimumab Clinical Trials 2 and 3: Study Endpoints
SLE Treatments: MAbs/Biologics
Belimumab Clinical Trials 2 and 3: Efficacy
SLE Treatments: MAbs/Biologics
Belimumab Clinical Trials 2 and 3: Efficacy
Belimumab Clinical Trials 2 and 3: Warnings and Pre...
SLE Treatments: MAbs/Biologics
Belimumab Clinical Trials 2 and 3: Efficacy
SLE Treatments: MAbs/Biologics
Belimumab Clinical Trials 2 and 3: Warnings and Precautions
SLE Treatments: MAbs/Biologics
MAbs/Biologics: Rituximab
Rituximab: Mode of Action
Rituximab: Efficacy
Rituximab: Si...
SLE Treatments: MAbs/Biologics
MAbs/Biologics: Rituximab
SLE Treatments: MAbs/Biologics
Rituximab: Mode of Action
SLE Treatments: MAbs/Biologics
Rituximab: Efficacy
SLE Treatments: MAbs/Biologics
Rituximab: Side Effects
SLE Treatments: MAbs/Biologics
MAbs/Biologics: Abatacept
Abatacept: Efficacy
Abatacept: Side Effects
SLE Treatments: MAbs/Biologics
MAbs/Biologics: Abatacept
SLE Treatments: MAbs/Biologics
Abatacept: Efficacy
SLE Treatments: MAbs/Biologics
Abatacept: Side Effects
SLE Treatments: MAbs/Biologics
MAbs/Biologics: Infliximab
Infliximab: Mode of Action
Infliximab: Efficacy and Safety
SLE Treatments: MAbs/Biologics
MAbs/Biologics: Infliximab
SLE Treatments: MAbs/Biologics
Infliximab: Mode of Action
SLE Treatments: MAbs/Biologics
Infliximab: Efficacy and Safety
SLE Treatments: MAbs/Biologics
MAbs/Biologics: Eculizumab
MAbs/Biologics: Ustekinumab
SLE Treatments: MAbs/Biologics
MAbs/Biologics: Eculizumab
SLE Treatments: MAbs/Biologics
MAbs/Biologics: Ustekinumab
SLE Treatments: Other
Danazol
SLE Treatments: Other
Plasmapheresis
SLE Treatments: Other
Plasmapheresis
SLE Treatments: Other
Plasmapheresis
SLE Treatments: Other
Other: Dialysis
Other: Renal Transplantation
Combination Therapies
SLE Treatments: Other
Other: Dialysis
SLE Treatments: Other
Other: Renal Transplantation
SLE Treatments: Other
Combination Therapies
Emerging Therapies for SLE
Emerging Therapies for SLE
Summary: Psoriasis
Cytokines Trigger
Impact of Psoriasis
Psychosocial Impact: Impaired Relationships
Effect on Social, Personal and Work Life
Mechanisms of Action
Corticosteroid Mechanism of Action
Beta 2 Adrenergic Agonist
Leukotriene Modifiers
Mechanisms of Action
Corticosteroid Mechanism of Action
Mechanisms of Action
Beta 2 Adrenergic Agonist
Mechanisms of Action
Leukotriene Modifiers
Variables
Demographic and Comorbid Variables
IgE and Omalizumab
IgE and Omalizumab
FEV1: Forced Expiratory Volume
FEV1: Forced Expiratory Volume
PEF: Peak Expiratory Flow
PEF: Peak Expiratory Flow
Introduction: Psoriasis
Definition of Psoriasis
Psoriasis Skin Dysregulation
Introduction: Psoriasis
Definition of Psoriasis
Introduction: Psoriasis
Psoriasis Skin Dysregulation
Potential Factors in the Development of Psoriasis
Potential Factors in Etiology of Psoriasis
Genetic Factors
Infectious Factors
Drug an...
Potential Factors in the Development of Psoriasis
Potential Factors in Etiology of Psoriasis
Potential Factors in the Development of Psoriasis
Genetic Factors
Potential Factors in the Development of Psoriasis
Infectious Factors
Potential Factors in the Development of Psoriasis
Drug and Environmental Factors
Potential Factors in the Development of Psoriasis
Geographical Location
Potential Factors in the Development of Psoriasis
Stress
Potential Factors in the Development of Psoriasis
Sites of Trauma: Koebner Phenomenon
Physiology of Immune System Dysregulation
Overview of Immune Dysregulation
Physiology of Immune System Dysregulation
Dermal Dendritic Cell Activation
Physiology of Immune System Dysregulation
T Cell Activation
Physiology of Immune System Dysregulation
Cytokines
T Cell Cytokines
Physiology of Immune System Dysregulation
Cytokines
Physiology of Immune System Dysregulation
T Cell Cytokines
Physiology of Immune System Dysregulation
T Regulatory Cells (Tregs)
Cytokines Trigger
Physiology of Immune System Dysregulation
Keratinocytes and Cytokines
Keratinocyte Remodeling
Physiology of Immune System Dysregulation
T Regulatory Cells (Tregs)
Physiology of Immune System Dysregulation
Cytokines Trigger
Physiology of Immune System Dysregulation
Cytokines Trigger
Physiology of Immune System Dysregulation
Cytokines Trigger
Physiology of Immune System Dysregulation
Keratinocytes and Cytokines
Physiology of Immune System Dysregulation
Keratinocyte Remodeling
Physiology of Immune System Dysregulation
Pathophysiology of Psoriasis
Types of Psoriasis
Types of Psoriasis
Psoriatic Arthritis
Psoriatic Arthritis (PsA)
Psoriatic Arthritis
Pathophysiology of Psoriatic Arthritis (PsA)
Psoriatic Arthritis (PsA) Pathophysiology
Psoriatic Arthritis
Pathophysiology of Psoriatic Arthritis (PsA)
Psoriatic Arthritis
Psoriatic Arthritis (PsA) Pathophysiology
Psoriatic Arthritis
Psoriatic Arthritis (PsA) Pathophysiology
Summary: Psoriasis
Psoriasis Definition
Potential Factors in Etiology of Psoriasis
Pathophysiology of Psorias...
Summary: Psoriasis
Psoriasis Definition
Summary: Psoriasis
Potential Factors in Etiology of Psoriasis
Summary: Psoriasis
Pathophysiology of Psoriasis
Summary: Psoriasis
Cytokines Trigger
Types of Psoriasis
Summary: Psoriasis
Types of Psoriasis
Introduction: Psoriasis
Introduction: Psoriasis
Epidemiology
Prevalence: Definition
Clinical Features/Presentation
Manifestations: Overview
Epidemiology
Prevalence
Epidemiology
Incidence
Age of Onset
Gender and Age
Epidemiology
Incidence
Epidemiology
Age of Onset
Epidemiology
Gender and Age
Epidemiology
Mortality and Survival
Clinical Features/Presentation
Signs and Symptoms
Clinical Features/Presentation
Manifestations: Overview
Areas of Skin Involvement and Extent of Involvement
Types of Psor...
Clinical Features/Presentation
Areas of Skin Involvement and Extent of Involvement
Clinical Features/Presentation
Types of Psoriasis
Clinical Features/Presentation
Extracutaneous Manifestations
Typical Course of Plaque Psoriasis
Onset, Episodes, Flare-Ups, Triggers
Impact of Psoriasis
Overview: Impact of Psoriasis
Impact of Psoriasis
Psychological Impact: Depression, Anxiety, and Stress
Impact of Psoriasis
Psychosocial Impact: Impaired Relationships
Impact of Psoriasis
Effect on Social, Personal and Work Life
Impact of Psoriasis
Physical Impact
Impact of Psoriasis
Physical Impact
Impact of Psoriasis
Physical Impact
Psoriasis Therapies
OTC Topical Coal Tar
Impact of Psoriasis
Economic Impact
Occupational Impact
Impact of Psoriasis
Economic Impact
Impact of Psoriasis
Occupational Impact
Impact of Psoriasis
Patient Scenario 1
Impact of Psoriasis
Patient Scenario 2
Impact of Psoriasis
Patient Scenario 3
Diagnostic Methods of Criteria for Psoriasis
Physicians Who Diagnose Psoriasis
Diagnostic Methods
Typical Presentation at Diagnosis
Diagnostic Methods of Criteria for Psoriasis
Physicians Who Diagnose Psoriasis
Diagnostic Methods of Criteria for Psoriasis
Diagnostic Methods
Diagnostic Methods of Criteria for Psoriasis
Typical Presentation at Diagnosis
Diagnostic Methods of Criteria for Psoriasis
Patient History
Diagnostic Criteria
Diagnostic Methods of Criteria for Psoriasis
Patient History
Diagnostic Methods of Criteria for Psoriasis
Diagnostic Criteria
Diagnostic Methods of Criteria for Psoriasis
Differential Diagnosis
Diagnostic Methods of Criteria for Psoriasis
Severity of Psoriasis
Diagnostic Methods of Criteria for Psoriasis
No Widely Accepted Definition
Clinical Assessment Tools in Psoriasis
Clinical Assessment Tools
Summary: Psoriasis
Prevalence
Incidence
Cutaneous and Extracutaneous Manifestations
Onset, Episodes, Fla...
Summary: Psoriasis
Prevalence
Summary: Psoriasis
Incidence
Summary: Psoriasis
Cutaneous and Extracutaneous Manifestations
Summary: Psoriasis
Onset, Episodes, Flare-Ups, Triggers
Summary: Psoriasis
Complications and Comorbidities of Psoriasis
Summary: Psoriasis
Impact of Psoriasis
Summary: Psoriasis
Diagnostic Methods
Typical Presentation at Diagnosis
Severity of Psoriasis
Clinical A...
Summary: Psoriasis
Diagnostic Methods
Summary: Psoriasis
Typical Presentation at Diagnosis
Summary: Psoriasis
Severity of Psoriasis
Summary: Psoriasis
Clinical Assessment Tools
Goals of Treatment
Primary Treatment Goals
Patient Compliance and Adherence
Reasonable Expectations for Patie...
Goals of Treatment
Primary Treatment Goals
Goals of Treatment
Patient Compliance and Adherence
Goals of Treatment
Reasonable Expectations for Patients
Treatment Teams
Treatment Team
Emotional Support
Treatment Teams
Treatment Team
Treatment Teams
Emotional Support
Choice of Therapy
Benefit/Risk
Psoriasis Severity Affects Treatment Choice
Choice of Therapy
Benefit/Risk
Choice of Therapy
Psoriasis Severity Affects Treatment Choice
Treatment Guidelines
Overview of Treatment Guidelines
Guidelines for Treatment of Psoriasis Patients Limited Disease
Treatment Guidelines
Overview of Treatment Guidelines
Treatment Guidelines
Guidelines for Treatment of Psoriasis Patients Limited Disease
Treatment Guidelines
Management of Subtypes of Psoriasis Patients with Limited Disease
FDA Pregnancy Drug Risk Categ...
Treatment Guidelines
Management of Subtypes of Psoriasis Patients with Limited Disease
Treatment Guidelines
Management of Subtypes of Psoriasis Patients with Limited Disease
Treatment Guidelines
Management of Subtypes of Psoriasis Patients with Limited Disease
Treatment Guidelines
FDA Pregnancy Drug Risk Categories
Treatment Guidelines
Management of Subtypes of Psoriasis Patients with Limited Disease
Treatment Guidelines
Management of Subtypes of Psoriasis Candidates for UV-Based, Oral PUVA or Systemic Therapy
Mana...
Treatment Guidelines
Management of Subtypes of Psoriasis Candidates for UV-Based, Oral PUVA or Systemic Therapy
Treatment Guidelines
Management of Subtypes of Psoriasis Erythrodermic Psoriasis
Treatment Guidelines
Management of Subtypes of Psoriasis Adults with Palmoplantar Psoriasis
Treatment Guidelines
Management of Subtypes of Psoriasis Extensive Chronic Plaque Psoriasis
Psoriasis Therapies
Psoriasis Therapies
Psoriasis Therapies
Topical Overview
Psoriasis Therapies
Topical Glucocorticoids
Topical Glucocorticoids: Mechanism of Action
Psoriasis Therapies
Topical Glucocorticoids
Psoriasis Therapies
Topical Glucocorticoids: Mechanism of Action
Psoriasis Therapies
Topical Glucocorticoids: Therapeutic Regimens
Psoriasis Therapies
Therapeutic Efficacy: Plaque Psoriasis
Psoriasis Therapies
Therapeutic Efficacy: Scalp Psoriasis
Psoriasis Therapies
Topical Glucocorticoids: Adverse Effects
Psoriasis Therapies
Topical Vitamin D Analogs
Topical Vitamin D Analogs: Mechanism of Action
Topical Vitamin D...
Psoriasis Therapies
Topical Vitamin D Analogs
Psoriasis Therapies
Topical Vitamin D Analogs: Mechanism of Action
Psoriasis Therapies
Topical Vitamin D Analogs: Therapeutic Efficacy
Psoriasis Therapies
Topical Vitamin D Analogs: Adverse Effects
Psoriasis Therapies
Systemic Therapies: Methotrexate
Psoriasis Therapies
Topical Retinoids: Tazarotene
Therapeutic Efficacy: Tarazotene Use
Therapeutic Efficacy: C...
Psoriasis Therapies
Topical Retinoids: Tazarotene
Psoriasis Therapies
Therapeutic Efficacy: Tarazotene Use
Psoriasis Therapies
Therapeutic Efficacy: Combination Therapy
Psoriasis Therapies
Topical Retinoids: Adverse Effects
Topical Anthralin
Topical Anthralin: Therapeutic Use
Psoriasis Therapies
Topical Retinoids: Adverse Effects
Psoriasis Therapies
Topical Anthralin
Psoriasis Therapies
Topical Anthralin: Therapeutic Use
Psoriasis Therapies
OTC Topical Coal Tar
OTC Topical Salicylic Acid
OTC Moisturizers and Emollients
Psoriasis Therapies
OTC Topical Salicylic Acid
Psoriasis Therapies
OTC Moisturizers and Emollients
Psoriasis Therapies
Phototherapy Overview
Phototherapy Ultraviolet B (UVB) (290 to 320 nm)
Psoriasis Therapies
Phototherapy Overview
Psoriasis Therapies
Phototherapy Ultraviolet B (UVB) (290 to 320 nm)
Psoriasis Therapies
Photochemotherapy
Excimer Laser Therapy (High Energy 308 nm)
Psoriasis Therapies
Photochemotherapy
Psoriasis Therapies
Excimer Laser Therapy (High Energy 308 nm)
Psoriasis Therapies
Systemic Therapies: Methotrexate
Systemic Therapies Overview
Methotrexate: Mechanism of Ac...
Psoriasis Therapies
Systemic Therapies Overview
Psoriasis Therapies
Methotrexate: Mechanism of Action
Psoriasis Therapies
Methotrexate: Adverse Effects
Psoriasis Therapies
Methotrexate: Clinical Efficacy
Psoriasis Therapies
Systemic Therapies: Cyclosporine A (CsA)
Cyclosporine A (CsA): Mechanism of Action
Cyclosp...
Psoriasis Therapies
Systemic Therapies: Cyclosporine A (CsA)
Psoriasis Therapies
Cyclosporine A (CsA): Mechanism of Action
Psoriasis Therapies
Cyclosporine A (CsA): Clinical Efficacy
Psoriasis Therapies
Cyclosporine A (CsA): Adverse Effects
Psoriasis Therapies
Systemic Therapies: Retinoids
Retinoids: Mechanism of Action
Retinoids: Clinical Efficacy
Psoriasis Therapies
Systemic Therapies: Retinoids
Psoriasis Therapies
Retinoids: Mechanism of Action
Psoriasis Therapies
Retinoids: Clinical Efficacy
Psoriasis Therapies
Retinoids: Adverse Effects
Psoriasis Therapies
Systemic Therapies: Off-Label Agents
Off-Label Agents: Clinical Efficacy and Safety
Biolog...
Psoriasis Therapies
Systemic Therapies: Off-Label Agents
Psoriasis Therapies
Off-Label Agents: Clinical Efficacy and Safety
Psoriasis Therapies
Biologics: TNF-Targeted Agents
Psoriatic Arthritis Therapies
Psoriatic Arthritis Therapies: Overview
Treatment Recommendations
Psoriatic Arthritis Therapies
Psoriatic Arthritis Therapies: Overview
Psoriatic Arthritis Therapies
Treatment Recommendations
Psoriatic Arthritis Therapies
Symptomatic Treatment
Symptomatic Treatment: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Psoriatic Arthritis Therapies
Symptomatic Treatment
Psoriatic Arthritis Therapies
Symptomatic Treatment: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Psoriatic Arthritis Therapies
Disease-Modifying Anti-Rheumatic Drugs (DMARDs)
Disease-Modifying Anti-Rheumatic Drugs (DMARDs)...
Psoriatic Arthritis Therapies
Disease-Modifying Anti-Rheumatic Drugs (DMARDs)
Psoriatic Arthritis Therapies
Disease-Modifying Anti-Rheumatic Drugs (DMARDs): Biologics
Psoriatic Arthritis Therapies
Other Options
Summary: Psoriasis Treatments
Goals of Psoriasis Treatment
Choice of Therapy
Treatment Guidelines
Psoriasis Therapi...
Summary: Psoriasis Treatments
Goals of Psoriasis Treatment
Summary: Psoriasis Treatments
Choice of Therapy
Summary: Psoriasis Treatments
Treatment Guidelines
Summary: Psoriasis Treatments
Psoriasis Therapies
Summary: Psoriasis Treatments
Psoriatic Arthritis Therapies
Introduction: Psoriasis Therapies and Treatments
Introduction: Psoriasis Therapies and Treatments
Introduction: Biologics for Psoriasis
Biologics, What Are They?
Conventional Versus Biologic Therapies
Biologics: Administration
Introduction: Biologics for Psoriasis
Biologics, What Are They?
Introduction: Biologics for Psoriasis
Conventional Versus Biologic Therapies
Introduction: Biologics for Psoriasis
Biologics: Administration
Immunosuppression
Immunosuppression
Tuberculosis (TB)
Tuberculosis Testing and Monitoring
Immunosuppression
Immunosuppression
Immunosuppression
Tuberculosis (TB)
Tuberculosis Testing and Monitoring
Immunosuppression
Tuberculosis (TB)
Immunosuppression
Tuberculosis Testing and Monitoring
Guidelines for Use of Biologics
Choice of Therapy
Choice of Therapy: Treatment Choice and Guidelines
Guidelines for Use of Biologics
Choice of Therapy
Guidelines for Use of Biologics
Choice of Therapy: Treatment Choice and Guidelines
Biologic Targets
Pathology of Psoriasis
T-Cell Cytokines
Biologic Targets
Biologic Targets
Pathology of Psoriasis
Biologic Targets
T-Cell Cytokines
Biologic Targets
Biologic Targets
Biologic Targets
Structural Differences in TNF-Blocking Biologics
Functional Differences in TNF-Blocking Agents
Biologic Targets
Structural Differences in TNF-Blocking Biologics
Biologic Targets
Functional Differences in TNF-Blocking Agents
Biologic Targets
IL-12/23 Antibody
Adalimumab
Overview: Description
Indication
Dosage and Administration
Adalimumab
Overview: Description
Adalimumab
Indication
Adalimumab
Dosage and Administration
Adalimumab
Pivotal Trials
Pivotal Trials: Psoriasis Trial I
Psoriasis Trial I: Endpoints
Psorias...
Adalimumab
Pivotal Trials
Adalimumab
Pivotal Trials: Psoriasis Trial I
Psoriasis Trial I: Endpoints
Psoriasis Trial I: Efficacy
Adalimumab
Pivotal Trials: Psoriasis Trial I
Adalimumab
Psoriasis Trial I: Endpoints
Adalimumab
Psoriasis Trial I: Efficacy
Adalimumab
Pivotal Trials: Psoriasis Trial II
Psoriasis Trial II: Efficacy
Adverse Reactions
Adalimumab
Pivotal Trials: Psoriasis Trial II
Adalimumab
Psoriasis Trial II: Efficacy
Adalimumab
Adverse Reactions
Adalimumab
Adalimumab Warnings
Infliximab
Overview: Description of Infliximab
Infliximab Indication
Dosage and Administration
Infliximab
Overview: Description of Infliximab
Infliximab
Infliximab Indication
Infliximab
Dosage and Administration
Infliximab
Pivotal Trials: Overview
Psoriasis Trial I: Study Design
Psoriasis Trial II: Study Design
Infliximab
Pivotal Trials: Overview
Infliximab
Psoriasis Trial I: Study Design
Infliximab
Psoriasis Trial II: Study Design
Infliximab
Psoriasis Trial III: Study Design
Infliximab
Pivotal Trials: Endpoints
Infliximab
Pivotal Trials: Efficacy of Induction
Infliximab
Pivotal Trials: Efficacy of Maintenance
Infliximab Safety
Infliximab
Pivotal Trials: Efficacy of Maintenance
Infliximab
Infliximab Safety
Infliximab
Safety: Boxed Warning
Etanercept
Overview: Description of Etanercept
Etanercept Indication
Dosage and Administration
Etanercept
Overview: Description of Etanercept
Etanercept
Etanercept Indication
Etanercept
Dosage and Administration
Etanercept
Pivotal Trials: Overview
Psoriasis Trial I: Study Design
Psoriasis Trial II: Study Design
Etanercept
Pivotal Trials: Overview
Etanercept
Psoriasis Trial I: Study Design
Etanercept
Psoriasis Trial II: Study Design
Etanercept
Psoriasis Trials I and II: Endpoints
Etanercept
Pivotal Trials: Efficacy
Etanercept
Safety
Etanercept
Safety: Boxed Warning
Ustekinumab
Overview: Ustekinumab
Indication
Dosage and Administration
Ustekinumab
Overview: Ustekinumab
Ustekinumab
Indication
Ustekinumab
Dosage and Administration
Ustekinumab
Pivotal Trials: Overview
Pivotal Trials: Trial Design
Pivotal Trials: Endpoints
Pivot...
Ustekinumab
Pivotal Trials: Overview
Ustekinumab
Pivotal Trials: Trial Design
Ustekinumab
Pivotal Trials: Endpoints
Ustekinumab
Pivotal Trials: Efficacy
Efficacy: Effect of Patient Weight
Efficacy: Trial I through Week...
Ustekinumab
Pivotal Trials: Efficacy
Ustekinumab
Efficacy: Effect of Patient Weight
Ustekinumab
Efficacy: Trial I through Week 52
Ustekinumab
Ustekinumab Safety
Summary: Psoriasis and Biologics
Psoriasis
Immunosuppression
Choice of Therapy
Biologic Targets
Combination Thera...
Summary: Psoriasis and Biologics
Psoriasis
Summary: Psoriasis and Biologics
Immunosuppression
Summary: Psoriasis and Biologics
Choice of Therapy
Summary: Psoriasis and Biologics
Biologic Targets
Summary: Psoriasis and Biologics
Combination Therapy
Goals of Treatment
Patient Education and Goals
Monoclonal Antibodies in Action
Effector Mechanisms - Overview
Neutralization of Circulating Factor
Antibody-Dependent Cel...
TNF-Targeted Biologics in Current Use - Etanercept
Mechanism of Action: Etanercept
Pathophysiology
Summary of RA Pathology
Summary of RA Pathology: T Cells
Summary of RA Pathology: B Cells
Pathophysiology
Summary of RA Pathology
Pathophysiology
Summary of RA Pathology: T Cells
Pathophysiology
Summary of RA Pathology: B Cells
Summary of RA Pathology: Antigen Presentation
Summary of ...
Pathophysiology
Summary of RA Pathology: B Cells
Pathophysiology
Summary of RA Pathology: Antigen Presentation
Pathophysiology
Summary of RA Pathology: Direct and Indirect Production of Proinflammatory Cytokines
Pathophysiology
Summary of RA Pathology: Production of autoantibodies
NSAIDs
Mechanism of Action (MOA): NSAIDs and COX Enzymes
Glucocorticoids
Mechanism of Action (MOA): Glucocorticoids
Nonbiologic DMARDs: Methotrexate
Mechanism of Action (MOA): Dihydrofolate Reductase (DHFR)
Nonbiologic DMARDs: Leflunomide
Mechanism of Action (MOA): Leflunomide
Monoclonal Antibodies
Biologic Therapies
Monoclonal Antibodies
Monoclonal Antibody Structure
Monoclonal Antibodies
Monoclonal Antibody Production
Monoclonal Antibody Production: Knowledge Check
Monoclonal Antibodies
Monoclonal Antibody Production
Monoclonal Antibodies in Action
Effector Mechanisms - Overview
Monoclonal Antibodies in Action
Neutralization of Circulating Factor
Monoclonal Antibodies in Action
Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC)
Monoclonal Antibodies in Action
Complement Dependent Cytotoxicity (CDC)
Monoclonal Antibodies in Action
Receptor Binding: Cross-linking
Monoclonal Antibodies in Action
Receptor Binding: Blockade/activation
Monoclonal Antibodies in Action
Conjugate Delivery: Toxin/Radionuclide
Monoclonal Antibodies in Action
Conjugate Delivery: Antibody-Directed Enzyme Prodrug Therapy (ADEPT)
TNF-Targeted Biologics in Current Use - Infliximab
Mechanism of Action (MOA): Infliximab
Other Biologics in Current Use - Anakinra
Mechanism of Action (MOA): Anakinra & IL-1Ra
Biologics in Current Use - Abatacept
Mechanism of Action (MOA): Abatacept & CTLA4
Other Biologics in Current Use - Rituximab
Mechanism of Action (MOA): Rituximab
Pannus at the Cellular Level
Synovial Pannus
Joints Affected by RA
Joints Affected by RA
Joints Affected by RA
Joints Affected by RA
Synovitis and the Synovial Pannus
Synovial Joints
Exercise: Nor...
Joints Affected by RA
Synovitis and the Synovial Pannus
Pannus at the Cellular Level
Lymphocytes: T Cells and B Cells
B Cells in RA
B Cells in RA
T Cells in RA
T Cells in RA
Helper T Cells: CD4+
Type I and Type 2 Helper T Cells
Antigen-Presentin...
Joints Affected by RA
Synovial Joints
Pannus at the Cellular Level
Synovial Pannus
Lymphocytes: T Cells and B Cells
A Joint Affected by RA
The Synovium
Pannus at the Cellular Level
A Joint Affected by RA
Pannus at the Cellular Level
The Synovium
Pannus at the Cellular Level
Neutrophils
Pannus at the Cellular Level
Macrophages
Pannus at the Cellular Level
Osteoclasts
T Cells in RA
T Cells in RA
T Cells in RA
Helper T Cells: CD4+
T Cells in RA
Type I and Type 2 Helper T Cells
T Cells in RA
Antigen-Presenting Cell and Antigen Fragment on MHC
B Cells in RA
B Cells in RA
Antigen Presentation
Normal B Cells
Antigen Presentation by an APC
B Cells in RA
Antigen Presentation
B Cells in RA
Normal B Cells
B Cells in RA
Antigen Presentation by an APC
B Cells in RA
The B Cell as an APC
B Cells in RA
Autoantibody Production
Autoantibody Production: How Antibodies Work
Autoantibody Producti...
B Cells in RA
Autoantibody Production
B Cells in RA
Autoantibody Production: How Antibodies Work
B Cells in RA
Autoantibody Production: Macrophages
B Cells in RA
Autoantibody Production: Rheumatoid Factor
B Cells in RA
B Cell Receptors
B Cells in RA
Pro-Inflammatory Cytokine Production
Learning Objectives
Learning Objectives
Pathophysiology
The Inflammatory Process in RA
Introduction: Rheumatoid Arthritis
Introduction: Rheumatoid Arthritis
Pathophysiology
The Inflammatory Process in RA
The Inflammatory Process in RA
Proinflammatory Pathways
The Inflammatory Process in RA
Response Regulation
Pathophysiology
Role of T Cells: Migration and Activation
Pathophysiology
Role of T Cells: Expression
Pathophysiology
Role of B Cells
Pathophysiology
Antigen Presentation
Pathophysiology
Cytokine and Autoantibody Production
Pathophysiology
B-Cell Regulation: BAFF/TNF-Super-family
Diagnosis of RA
2010 Rheumatoid Arthritis Classification - Goal and Eligibility
Pathophysiology
Role of B Cells
Pathophysiology
Rheumatoid Factor (RF)
Pathophysiology
Role of RF-Producing B Cells
Pathophysiology
Anti-citrullinated protein antibodies (ACPA)
Pathophysiology
Autoantibodies
Pathophysiology
Roles of Other Immune System Cells
Learning Objectives
Learning Objectives
Diagnosis of RA
Clinical Measures - Synovial Fluid Analysis
Introduction
What Is Rheumatoid Arthritis? Chronic Inflammation
Introduction
What Is Rheumatoid Arthritis? Organ Involvement
Epidemiology
Prevalence
Epidemiology
Incidence
Epidemiology
Mortality and Survival
Disease Definition and Clinical Course
Clinical Features and Presentation
Disease Definition and Clinical Course
Course of Disease
Disease Definition and Clinical Course
Effect of Disease Modifying Therapy
Disease Definition and Clinical Course
Work Disability
Diagnosis of RA
Overview - Diagnosis of RA
Diagnosis of RA
2010 Rheumatoid Arthritis Classification
Diagnosis of RA
2010 Rheumatoid Arthritis Classification - Criteria
Diagnosis of RA
2010 Rheumatoid Arthritis Classification - Other Clinical Presentations
Diagnosis of RA
2010 Rheumatoid Arthritis Classification - Definitions
Diagnosis of RA
2010 Rheumatoid Arthritis Classification - Comparison to 1987 Classification
Diagnosis of RA
Clinical Measures - Overview
Diagnosis of RA
Clinical Measures - Complete Blood Cell (CBC) Count
Diagnosis of RA
Clinical Measures - Imaging Studies
Diagnosis of RA
Clinical Measures - Other Tests
Diagnosis of RA
Clinical Measures - Identification of Biomarkers
Diagnosis of RA
Clinical Measures - Biomarkers and Rheumatoid Factor
Diagnosis of RA
Clinical Measures - Measures used in Clinical Trials
Diagnosis of RA
Measures Used in Clinical Trials - Assessment of Joint Damage by X-Ray
Diagnosis of RA
Measures Used in Clinical Trials - ACR
Diagnosis of RA
Measures Used in Clinical Trials - DAS
Diagnosis of RA
Measures Used in Clinical Trials - EULAR
Diagnosis of RA
Differential Diagnosis
Complications of RA
Rheumatoid Nodules
Complications of RA
Complications of RA
Complications of RA
Major Organs Affected by RA
Risk Factors
Genetics and Environmental Factors
Risk Factors
Additional Postulated Risk Factors: Infectious Agents and Vaccination Complications
Risk Factors
Additional Postulated Risk Factors: Hormones and Education Level
Learning Objectives
Learning Objectives
Introduction
Introduction: Rheumatoid Arthritis Treatment
Therapeutic Approach
Therapeutic Approach: ACR Guidelines
Therapeutic Approach
Therapeutic Approach: Differences from Earlier ACR Recommendations
Analgesics
Analgesics
NSAIDs
Introduction: NSAIDs
Glucocorticoids
Glucocorticoids: Use in RA
Glucocorticoids
Use in RA: ACR Guidelines
Non-biologic DMARDs
Introduction: DMARDs
Non-biologic DMARDs
Antimalarials (hydroxychloroquine)
Non-biologic DMARDs
Sulfasalazine
Non-biologic DMARDs: Methotrexate
Introduction: Methotrexate (MTX)
Non-biologic DMARDs: Methotrexate
Methotrexate: Efficacy
Non-biologic DMARDs: Methotrexate
Pivotal Clinical Studies
Non-biologic DMARDs: Methotrexate
Pivotal Clinical Studies: Methotrexate
Non-biologic DMARDs: Methotrexate
Clinical Studies: Multidrug Combinations
Non-biologic DMARDs: Methotrexate
MTX in Combination: Two Year Randomized, Double-Blind, Placebo-Controlled Trial
Non-biologic DMARDs: Methotrexate
Methotrexate Use: RA Indication
Non-biologic DMARDs: Methotrexate
Methotrexate: Use Contraindications
Non-biologic DMARDs: Methotrexate
Methotrexate Dosage: Oral
Non-biologic DMARDs: Methotrexate
Methotrexate Dosage: Safety and Side Effects
Non-biologic DMARDs: Methotrexate
Safety Issues and Side Effects
Non-biologic DMARDs: Leflunomide
Introduction: Leflunomide
Non-biologic DMARDs: Leflunomide
Use: Indications, Contraindications, Safety Issues and Side Effects
Summary
Summary: Methotrexate (MTX)
Summary: RA Treatment Guidelines
Summary: RA Treatment Guidelines
Learning Objectives
Learning Objectives
Background on Biologic Therapies
Biologics in the Treatment of Rheumatoid Arthritis (RA)
Background on Biologic Therapies
Monoclonal Antibodies
Biologics in use for RA
Effector Mechanisms: TNFα
Biologics in use for RA
Effector Mechanisms: Inhibition of TNFα
Learning Objectives
Learning Objectives
Biologic DMARDs
Biologic DMARDs: Background
TNF-Targeted Biologics in Current Use - Etanercept
Use: Indication for Rheumatoid Arthritis, Dosage and Administration
Biologic DMARDs
Background: Adverse Events
TNF-Targeted Biologics in Current Use - Etanercept
Warnings: Etanercept
TNF-Targeted Biologics in Current Use - Infliximab
Use: Indication, Dosage and Administration for RA
TNF-Targeted Biologics in Current Use - Infliximab
Warnings: Infliximab
TNF-Targeted Biologics in Current Use - Adalimumab
Mechanism of Action: Adalimumab
TNF-Targeted Biologics in Current Use - Adalimumab
Use in RA: Indications, Dosage and Administration
TNF-Targeted Biologics in Current Use - Adalimumab
Dosage, Administration, and Warnings
TNF-Targeted Biologics in Current Use - Golimumab
Mechanism of Action: Golimumab
TNF-Targeted Biologics in Current Use - Golimumab
Use and Indication for RA: Golimumab
TNF-Targeted Biologics in Current Use - Golimumab
Warnings: Golimumab
TNF-Targeted Biologics in Current Use - Certolizumab Pegol
Mechanism of Action: Certolizumab Pegol
TNF-Targeted Biologics in Current Use - Certolizumab Pegol
Use, Indication for RA, Dosage and Administration: Certolizumab Pegol
TNF-Targeted Biologics in Current Use - Certolizumab Pegol
Warnings: Certolizumab Pegol
Other Biologics in Current Use - Anakinra
Use in RA, Indications, Dosage and Administration: Anakinra
Other Biologics in Current Use - Anakinra
Warnings: Anakinra
Biologics in Current Use - Abatacept
Use, Indication for RA, Dosage and Administration: Abatacept
Biologics in Current Use - Abatacept
Warnings: Abatacept
Other Biologics in Current Use - Rituximab
Use, Indication for RA, Dosage and Administration: Rituximab
Other Biologics in Current Use - Rituximab
Recommended Dose for Rheumatoid Arthritis and Concomitant Medications: Rituximab
Other Biologics in Current Use - Rituximab
Warnings: Rituximab
Other Biologics in Current Use - Tocilizumab
Mechanism of Action: Tocilizumab
Other Biologics in Current Use - Tocilizumab
Use, Indication, Dosage and Administration: Tocilizumab
Other Biologics in Current Use - Tocilizumab
Dosage Modifications: Tocilizumab
Other Biologics in Current Use - Tocilizumab
Warnings: Tocilizumab
Background of Clinical Trials
Initial studies with Monoclonal Antibodies
Background of Clinical Trials
Clinical Trials of Biologic RA Treatments
Clinical Trials of Biologic Agents
Introduction: Clinical Trials of Biologic Agents
Etanercept: Clinical Studies
Etanercept: Clinical Studies
Infliximab: Clinical Studies
Infliximab: Clinical Studies
Adalimumab: Clinical Studies
Adalimumab: Clinical Studies
Golimumab: Clinical Studies
Golimumab: Clinical Studies
Certolizumab Pegol: Clinical Studies
Certolizumab Pegol: Clinical Studies
Anakinra: Clinical Studies
Anakinra: Clinical Studies
Abatacept: Clinical Studies
Abatacept: Clinical Studies
Rituximab: Clinical Studies
Rituximab: Clinical Studies
Tocilizumab: Clinical Studies
Tocilizumab: Clinical Studies
Review of Clinical Trials and Meta-analyses of Biologic Agents
Comparisons of Clinical Trial Results
Review of Clinical Trials and Meta-analyses of Biologic Agents
Introduction: Review of Clinical Trials
Review of Clinical Trials and Meta-analyses of Biologic Agents
Biologic Treatments and Remission in Early RA
Review of Clinical Trials and Meta-analyses of Biologic Agents
Efficacy of Biologic Agent Monotherapy in MTX-Naive Patients
Review of Clinical Trials and Meta-analyses of Biologic Agents
Efficacy of Biologic Treatment and MTX Combination Therapy in MTX-Naive Patients
Review of Clinical Trials and Meta-analyses of Biologic Agents
Efficacy of Biologic Treatment and MTX Combination Therapy in MTX-Experienced Patients
Review of Clinical Trials and Meta-analyses of Biologic Agents
Efficacy of Combined Biologic Treatment and DMARD Therapy in DMARD-Experienced Patients
Review of Clinical Trials and Meta-analyses of Biologic Agents
Sequential Use of TNFα inhibitors
Review of Clinical Trials and Meta-analyses of Biologic Agents
Sequential Use of TNFα inhibitors: Comparing Studies
Anatomy and Physiology of the Skin: Introduction
Anatomy and Physiology of the Skin: Introduction
Anatomy and Physiology of the Skin: Introduction
Anatomy and Physiology of the Skin: Learning Objectives
Overview of Skin Structure and Function
Overview of Skin Structure and Function
Layers of the Skin: Epidermis
Layers of the Skin: Epidermis: Introduction
Layers of the Skin: Epidermis
Epidermis Layers
Layers of the Skin: Epidermis
Epidermal Layers
Layers of the Skin: Epidermis
Epidermal Functions: Keratinocyte Proliferation and Differentiation
Layers of the Skin: Epidermis
Epidermal Functions: Desquamation
Layers of the Skin: Epidermis
Other Cells of the Epidermis
Layers of the Skin: Dermal-Epidermal Junction, Dermis
Layers of the Skin: Dermal-Epidermal Junction, Dermis: Overview
Layers of the Skin: Dermal-Epidermal Junction, Dermis
Cells of the Dermis
Layers of the Skin: Dermal-Epidermal Junction, Dermis
Other Components of the Dermis
Layers of the Skin: Dermal-Epidermal Junction, Dermis
Other Components of the Dermis: Ground Substance
Immune System of the Skin
Immune System of the Skin: Overview
Immune System of the Skin
Skin Barrier
Immune System of the Skin
Innate-Acquired Immune System Interactions
Immune System of the Skin
Acquired Immune Responses
Immune System of the Skin
Acquired Immune Response Memory
Anatomy and Physiology of the Skin: Summary
Anatomy and Physiology of the Skin: Summary
Atopic Dermatitis: Introduction
Atopic Dermatitis: Introduction
Normal Skin Anatomy
The Structure and Function of Normal Skin
Definition of Atopic Dermatitis
Definition of Atopic Dermatitis
Epidemiology
Global Prevalence of AD
Epidemiology
Prevalence of AD in the United States
Epidemiology
Historical Trends in the Prevalence of AD
Natural History
Natural History
Risk Factors
AD and Environmental Risk Factors
Risk Factors
Genetic Risk Factors in AD
Pathophysiology
Phosphodiesterases and the Pathogenesis of AD
Diagnosis
Diagnostic Criteria for AD
Diagnosis
EASI
Diagnosis
The Patient-Oriented Eczema Measure (POEM)
Diagnosis
Biomarkers in AD
view more